Jacqueline Zillioux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jacqueline Zillioux has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Howard B. Goldman
Glickman Urologic Institute, Lerner College of Medicine, Cleveland Clinic, Cleveland, USA
6 shared publications- Nora G. Kern
University of Virginia
5 shared publications David E. Rapp
Department of Urology, University of Virginia Health System, Charlottesville, Virginia
4 shared publications- David E. Rapp
Department of Urology, University of Virginia, Charlottesville, Virginia
4 shared publications Mikel Gray
Department of Urology University of Virginia Health Charlottesville Virginia USA
3 shared publications- Sarah Martin
Department of Urology, Glickman Urological and Kidney Institute Cleveland Clinic Foundation Cleveland Ohio USA
3 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Springer Nature in International Urogynecology Journal
- p. 1-33
Cumulative Incidence and Surgical Risk Factors for Severe Postoperative Complications in the Treatment of Primary Uterovaginal Prolapse: A Systematic Review and Meta-Analysis
Introduction and Hypothesis: Apical repairs for uterovaginal prolapse (UPOP) are generally elective procedures with significant quality-of-life benefit; however, uncommon and potentially severe complications may occur. Our goal was to perform a systematic review and meta-analysis to understand risks for and estimate the incidence of major complications of common surgical approaches to UPOP repair. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched MEDLINE and EMBASE through 11/11/25 for studies describing risk factors for, or incidence of, severe complications due to surgical UPOP repair. Data collected included risk factor analysis and incidence data for major intraoperative injury (bowel, bladder, ureteral, or nerve) and major surgical complications (transfusion, small bowel obstruction, perioperative death, mesh complication, reoperations, and readmissions, and sum of any major complication). Pooled proportions were estimated using a random-effects meta-analysis of proportions, and between-group comparisons were performed using mixed-effects meta-regression for major surgical approaches to UPOP repair (vaginal native tissue (VNT), minimally invasive sacrocolpopexy (MIS SCP), transvaginal mesh (TVM); all transabdominal MIS (laparoscopic/robotic), all vaginal reconstructive; VNT with hysterectomy, and VNT with hysteropexy). Results: Of the 8890 abstracts screened, 46 studies met the inclusion criteria. Overall quality of evidence was moderate. MIS had higher pooled incidence of intraoperative bowel injury compared to vaginal approaches (0.48%; CI 0.27–0.84 vs 0.18%; CI 0.09–0.35, p = 0.028); however, with lower risk of transfusion (0.35%; CI 0.14%–0.87% vs 0.99%; CI 0.67%–1.46%, p = 0.04). Total intraoperative injury estimates were similar between groups (0.11%; CI 0.01–0.81 vs 0.65%; CI 0.20–2.06. p = 0.135). TVM was associated with higher total major complications (17.98%; CI 9.44–31.56) than VNT (5.01%; CI 3.07–8.07) or MIS SCP (6.41%; CI 4.13–9.84) p = 0.007. A narrative review of risk factors for surgical complications identified significant heterogeneity and low confidence in reported risk factors. Conclusions: Severe complications following repair of primary UPOP are infrequent. Abdominal MIS carry higher risk of bowel injury, with lower risk of transfusion compared to vaginal approaches. These data should inform shared decision-making for surgeons and patients considering surgical repair for primary UPOP.
- 21 October 2026
- Published by Springer Nature in International Urogynecology Journal
- p. 1-33
Open AccessCumulative Incidence and Surgical Risk Factors for Severe Postoperative Complications in the Treatment of Primary Uterovaginal Prolapse: A Systematic Review and Meta-Analysis
Introduction and Hypothesis: Apical repairs for uterovaginal prolapse (UPOP) are generally elective procedures with significant quality-of-life benefit; however, uncommon and potentially severe complications may occur. Our goal was to perform a systematic review and meta-analysis to understand risks for and estimate the incidence of major complications of common surgical approaches to UPOP repair. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched MEDLINE and EMBASE through 11/11/25 for studies describing risk factors for, or incidence of, severe complications due to surgical UPOP repair. Data collected included risk factor analysis and incidence data for major intraoperative injury (bowel, bladder, ureteral, or nerve) and major surgical complications (transfusion, small bowel obstruction, perioperative death, mesh complication, reoperations, and readmissions, and sum of any major complication). Pooled proportions were estimated using a random-effects meta-analysis of proportions, and between-group comparisons were performed using mixed-effects meta-regression for major surgical approaches to UPOP repair (vaginal native tissue (VNT), minimally invasive sacrocolpopexy (MIS SCP), transvaginal mesh (TVM); all transabdominal MIS (laparoscopic/robotic), all vaginal reconstructive; VNT with hysterectomy, and VNT with hysteropexy). Results: Of the 8890 abstracts screened, 46 studies met the inclusion criteria. Overall quality of evidence was moderate. MIS had higher pooled incidence of intraoperative bowel injury compared to vaginal approaches (0.48%; CI 0.27–0.84 vs 0.18%; CI 0.09–0.35, p = 0.028); however, with lower risk of transfusion (0.35%; CI 0.14%–0.87% vs 0.99%; CI 0.67%–1.46%, p = 0.04). Total intraoperative injury estimates were similar between groups (0.11%; CI 0.01–0.81 vs 0.65%; CI 0.20–2.06. p = 0.135). TVM was associated with higher total major complications (17.98%; CI 9.44–31.56) than VNT (5.01%; CI 3.07–8.07) or MIS SCP (6.41%; CI 4.13–9.84) p = 0.007. A narrative review of risk factors for surgical complications identified significant heterogeneity and low confidence in reported risk factors. Conclusions: Severe complications following repair of primary UPOP are infrequent. Abdominal MIS carry higher risk of bowel injury, with lower risk of transfusion compared to vaginal approaches. These data should inform shared decision-making for surgeons and patients considering surgical repair for primary UPOP.
- Open Access
- 25 September 2026
- Published by Springer Nature in International Urogynecology Journal
- p. 1-27
Management of Major Non-mesh Complications After Primary Uterovaginal Prolapse Surgery: A Systematic Review
Introduction: Major complications following uterovaginal prolapse (UPOP) repair are rare but carry significant morbidity. High quality evidence regarding their management is scarce. Our objective was to perform a systematic review of available evidence and develop standardized consensus-based clinical principles and algorithms for these complications. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we retrieved studies from MEDLINE, EMBASE, and clinicaltrials.gov through 11/11/25 describing management of major complications following UPOP surgery. GRADE criteria were used to assess quality. Expert opinion and Delphi process were used to develop consensus-based management algorithms and clinical principles. Results: Of the 8890 abstracts screened, 24 studies met eligibility criteria. Most studies were retrospective and case reports with overall low to very low quality of evidence. Studies on management of complications such as bowel and ureteral injury, neuropathic pain, pyometra, and hemorrhage were retrieved. Conclusions: This systematic review and consensus document addresses a critical void in pelvic floor surgery by establishing the first structured management framework for bowel, ureteral, neuropathic, pyometra, and hemorrhagic complications following UPOP surgery.
- 25 September 2026
- Published by Springer Nature in International Urogynecology Journal
- p. 1-27
Open AccessManagement of Major Non-mesh Complications After Primary Uterovaginal Prolapse Surgery: A Systematic Review
Introduction: Major complications following uterovaginal prolapse (UPOP) repair are rare but carry significant morbidity. High quality evidence regarding their management is scarce. Our objective was to perform a systematic review of available evidence and develop standardized consensus-based clinical principles and algorithms for these complications. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we retrieved studies from MEDLINE, EMBASE, and clinicaltrials.gov through 11/11/25 describing management of major complications following UPOP surgery. GRADE criteria were used to assess quality. Expert opinion and Delphi process were used to develop consensus-based management algorithms and clinical principles. Results: Of the 8890 abstracts screened, 24 studies met eligibility criteria. Most studies were retrospective and case reports with overall low to very low quality of evidence. Studies on management of complications such as bowel and ureteral injury, neuropathic pain, pyometra, and hemorrhage were retrieved. Conclusions: This systematic review and consensus document addresses a critical void in pelvic floor surgery by establishing the first structured management framework for bowel, ureteral, neuropathic, pyometra, and hemorrhagic complications following UPOP surgery.
- Open Access
- 27 July 2026
- Published by Wiley in Neurourology and Urodynamics
One Size Does Not Fit All: Establishing Anticipated Baseline Intravesical Pressures Adjusted for Position and Body Mass Index
Purpose: Accurate measurement of intravesical pressure (Pves) during multichannel urodynamic testing requires zeroing with reference to surrounding atmosphere, establishing a reference level for measuring Pves, and assessing response to coughs. We prospectively evaluated baseline resting Pves in the supine and sitting positions and used statistical modeling to establish reference ranges for patients undergoing urodynamic testing and examine the influence of age, sex, and BMI on these measurements. Methods: We prospectively evaluated adults undergoing multichannel urodynamic testing at a single institution. Initial resting Pves was recorded in both the supine and sitting positions following a standardized protocol using external dome (water‐charged) transducers. Linear mixed‐effects prediction models assessed associations between Pves and BMI, age, sex, and position. Results: The sample comprised 468 patients; 77% ( n = 360) were overweight or obese. The mean supine and sitting Pves were 12.7 and 26.0 cmH 2 O, respectively. The optimal linear mixed‐effects model for initial resting Pves included age, BMI, position, and the interaction between these variables. Predicted normal Pves ranged from 0.0 to 26.6 cmH 2 O (supine) and 7.3 to 43.6 cmH 2 O (sitting). Increasing BMI was strongly correlated with increasing Pves. Discussion: We identified model‐derived ranges for initial resting Pves in the supine and sitting positions that vary primarily with BMI. While current guideline‐recommended ranges remain broadly applicable, patients with higher BMIs are more likely to have values that lie above these thresholds. We also developed an online app that generates expected Pves ranges based on patient‐specific characteristics.
- 27 July 2026
- Published by Wiley in Neurourology and Urodynamics
Open AccessOne Size Does Not Fit All: Establishing Anticipated Baseline Intravesical Pressures Adjusted for Position and Body Mass Index
Purpose: Accurate measurement of intravesical pressure (Pves) during multichannel urodynamic testing requires zeroing with reference to surrounding atmosphere, establishing a reference level for measuring Pves, and assessing response to coughs. We prospectively evaluated baseline resting Pves in the supine and sitting positions and used statistical modeling to establish reference ranges for patients undergoing urodynamic testing and examine the influence of age, sex, and BMI on these measurements. Methods: We prospectively evaluated adults undergoing multichannel urodynamic testing at a single institution. Initial resting Pves was recorded in both the supine and sitting positions following a standardized protocol using external dome (water‐charged) transducers. Linear mixed‐effects prediction models assessed associations between Pves and BMI, age, sex, and position. Results: The sample comprised 468 patients; 77% ( n = 360) were overweight or obese. The mean supine and sitting Pves were 12.7 and 26.0 cmH 2 O, respectively. The optimal linear mixed‐effects model for initial resting Pves included age, BMI, position, and the interaction between these variables. Predicted normal Pves ranged from 0.0 to 26.6 cmH 2 O (supine) and 7.3 to 43.6 cmH 2 O (sitting). Increasing BMI was strongly correlated with increasing Pves. Discussion: We identified model‐derived ranges for initial resting Pves in the supine and sitting positions that vary primarily with BMI. While current guideline‐recommended ranges remain broadly applicable, patients with higher BMIs are more likely to have values that lie above these thresholds. We also developed an online app that generates expected Pves ranges based on patient‐specific characteristics.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 214 (5) , 530-538
Sacral Neuromodulation for Overactive Bladder in the Aging Population: Does Cognitive Impairment Impact Outcomes? A Prospective Clinical Trial
To evaluate the impact of cognitive impairment (CI) on sacral neuromodulation (SNM) outcomes in older patients, including progression to full implant, patient-reported outcome measures, and device utilization. This prospective trial recruited patients age ≥ 60 years scheduled for test-phase SNM for refractory overactive bladder (OAB). Screening for CI was completed and defined as Montreal Cognitive Assessment scores < 26/30.Patients underwent initial and follow-up assessments using validated questionnaires (OAB-q SF, IIQ7, UDI-6, PGI-I). Baseline functional status and technology comfort/use were assessed by novel questionnaire. The primary outcome of test-phase success (>50% improvement in baseline symptoms) was compared based on the presence of CI. Secondary outcomes included urinary questionnaire scores and device utilization. Of 92 patients recruited, 88 underwent test-phase SNM (mean age 73 ± 8 years, 89% female), and 63% had CI (Montreal Cognitive Assessment < 26). Baseline patient-reported measures of OAB symptom severity and impact were not statistically different between groups. Patients with CI had lower baseline technology use and confidence. Overall test-phase success was 89% and did not differ based on CI (91% vs 87%, P = .7). At 1-month follow-up, patients with CI demonstrated lower rates of appropriate SNM controller use; however, patient-reported outcomes did not differ. Older patients with OAB presenting for SNM have a high incidence of CI, which is associated with reduced comfort using technology. However, there was no evidence that CI affected SNM test-phase success or short-term patient-reported outcomes.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 214 (5) , 530-538
Sacral Neuromodulation for Overactive Bladder in the Aging Population: Does Cognitive Impairment Impact Outcomes? A Prospective Clinical Trial
To evaluate the impact of cognitive impairment (CI) on sacral neuromodulation (SNM) outcomes in older patients, including progression to full implant, patient-reported outcome measures, and device utilization. This prospective trial recruited patients age ≥ 60 years scheduled for test-phase SNM for refractory overactive bladder (OAB). Screening for CI was completed and defined as Montreal Cognitive Assessment scores < 26/30.Patients underwent initial and follow-up assessments using validated questionnaires (OAB-q SF, IIQ7, UDI-6, PGI-I). Baseline functional status and technology comfort/use were assessed by novel questionnaire. The primary outcome of test-phase success (>50% improvement in baseline symptoms) was compared based on the presence of CI. Secondary outcomes included urinary questionnaire scores and device utilization. Of 92 patients recruited, 88 underwent test-phase SNM (mean age 73 ± 8 years, 89% female), and 63% had CI (Montreal Cognitive Assessment < 26). Baseline patient-reported measures of OAB symptom severity and impact were not statistically different between groups. Patients with CI had lower baseline technology use and confidence. Overall test-phase success was 89% and did not differ based on CI (91% vs 87%, P = .7). At 1-month follow-up, patients with CI demonstrated lower rates of appropriate SNM controller use; however, patient-reported outcomes did not differ. Older patients with OAB presenting for SNM have a high incidence of CI, which is associated with reduced comfort using technology. However, there was no evidence that CI affected SNM test-phase success or short-term patient-reported outcomes.
- 20 October 2025
- Published by Springer Nature
- p. 401-415
Female Cystectomy: Pelvic Floor and Functional Perioperative Considerations
- 20 October 2025
- Published by Springer Nature
- p. 401-415
Female Cystectomy: Pelvic Floor and Functional Perioperative Considerations
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (9)
JUOP August 2025 Editorial: Anticholinergics—Does Treating the Bladder Harm the Brain?
- 1 September 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (9)
Open AccessJUOP August 2025 Editorial: Anticholinergics—Does Treating the Bladder Harm the Brain?
- Open Access
- 28 November 2024
- Published by Elsevier in Continence
- Vol. 13
Minimally invasive therapies for older patients with urgency urinary incontinence: Current evidence and recommendations
- 28 November 2024
- Published by Elsevier in Continence
- Vol. 13
Open AccessMinimally invasive therapies for older patients with urgency urinary incontinence: Current evidence and recommendations